Total Liabilities Summary of ALK-Abelló A/S

ALK-Abelló A/S's latest annual total liabilities in 2023 was 2.27 Billion DKK , down -1.77% from previous year.
ALK-Abelló A/S's latest quarterly total liabilities in 2024 Q2 was 2.12 Billion DKK , up 1.53% from previous quarter.
ALK-Abelló A/S reported annual total liabilities of 2.32 Billion DKK in 2022, down -1.28% from previous year.
ALK-Abelló A/S reported annual total liabilities of 2.35 Billion DKK in 2021, down -2.49% from previous year.
ALK-Abelló A/S reported quarterly total liabilities of 2.09 Billion DKK for 2024 Q1, down -8.12% from previous quarter.
ALK-Abelló A/S reported quarterly total liabilities of 2.27 Billion DKK for 2023 Q2, up 1.56% from previous quarter.

Annual Total Liabilities Chart of ALK-Abelló A/S (2023 - 2005)

Historical Annual Total Liabilities of ALK-Abelló A/S (2023 - 2005)

Year	Total Liabilities	Total Liabilities Growth
2023	2.27 Billion DKK	-1.77%
2022	2.32 Billion DKK	-1.28%
2021	2.35 Billion DKK	-2.49%
2020	2.41 Billion DKK	3.92%
2019	2.31 Billion DKK	37.54%
2018	1.68 Billion DKK	1.08%
2017	1.66 Billion DKK	-13.31%
2016	1.92 Billion DKK	23.73%
2015	1.55 Billion DKK	46.01%
2014	1.06 Billion DKK	4.51%
2013	1.01 Billion DKK	2.1%
2012	998 Million DKK	-15.92%
2011	1.18 Billion DKK	46.18%
2010	812 Million DKK	12.0%
2009	725 Million DKK	7.25%
2008	676 Million DKK	-4.65%
2007	709 Million DKK	2.01%
2006	695 Million DKK	-1.7%
2005	707 Million DKK	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	2.12 Billion DKK	1.53%
2024 Q1	2.09 Billion DKK	-8.12%
2023 Q2	2.27 Billion DKK	1.56%
2023 Q1	2.23 Billion DKK	-3.53%
2023 FY	2.27 Billion DKK	-1.77%
2023 Q4	2.27 Billion DKK	2.33%
2023 Q3	2.22 Billion DKK	-2.02%
2022 Q2	2.42 Billion DKK	4.76%
2022 Q4	2.32 Billion DKK	-0.6%
2022 Q3	2.33 Billion DKK	-3.59%
2022 Q1	2.31 Billion DKK	-1.66%
2022 FY	2.32 Billion DKK	-1.28%
2021 FY	2.35 Billion DKK	-2.49%
2021 Q1	2.46 Billion DKK	2.16%
2021 Q2	2.32 Billion DKK	-5.52%
2021 Q3	2.4 Billion DKK	3.35%
2021 Q4	2.35 Billion DKK	-2.25%
2020 FY	2.41 Billion DKK	3.92%
2020 Q1	2.36 Billion DKK	1.77%
2020 Q2	2.44 Billion DKK	3.39%
2020 Q3	2.37 Billion DKK	-2.87%
2020 Q4	2.41 Billion DKK	1.69%
2019 Q4	2.31 Billion DKK	22.18%
2019 Q1	1.93 Billion DKK	14.89%
2019 Q2	1.94 Billion DKK	0.52%
2019 Q3	1.89 Billion DKK	-2.52%
2019 FY	2.31 Billion DKK	37.54%
2018 Q3	1.57 Billion DKK	-4.09%
2018 Q4	1.68 Billion DKK	7.25%
2018 FY	1.68 Billion DKK	1.08%
2018 Q1	1.63 Billion DKK	-1.98%
2018 Q2	1.63 Billion DKK	0.24%
2017 FY	1.66 Billion DKK	-13.31%
2017 Q2	1.79 Billion DKK	-10.15%
2017 Q1	2 Billion DKK	3.95%
2017 Q4	1.66 Billion DKK	-4.36%
2017 Q3	1.74 Billion DKK	-2.95%
2016 FY	1.92 Billion DKK	23.73%
2016 Q2	1.66 Billion DKK	0.0%
2016 Q3	1.68 Billion DKK	1.57%
2016 Q4	1.92 Billion DKK	14.05%
2016 Q1	1.66 Billion DKK	6.82%
2015 Q3	1.46 Billion DKK	3.09%
2015 FY	1.55 Billion DKK	46.01%
2015 Q4	1.55 Billion DKK	5.93%
2015 Q2	1.42 Billion DKK	25.91%
2015 Q1	1.13 Billion DKK	6.2%
2014 Q4	1.06 Billion DKK	4.51%
2014 FY	1.06 Billion DKK	4.51%
2014 Q1	1.05 Billion DKK	3.24%
2014 Q2	1.02 Billion DKK	-3.04%
2014 Q3	1.01 Billion DKK	-0.1%
2013 Q3	999 Million DKK	-0.1%
2013 Q4	1.01 Billion DKK	2.0%
2013 FY	1.01 Billion DKK	2.1%
2013 Q1	1.03 Billion DKK	3.51%
2013 Q2	1 Billion DKK	-3.19%
2012 Q2	929 Million DKK	-22.78%
2012 Q1	1.2 Billion DKK	1.35%
2012 FY	998 Million DKK	-15.92%
2012 Q4	998 Million DKK	4.61%
2012 Q3	954 Million DKK	2.69%
2011 FY	1.18 Billion DKK	46.18%
2011 Q1	928 Million DKK	14.29%
2011 Q2	855 Million DKK	-7.87%
2011 Q3	853 Million DKK	-0.23%
2011 Q4	1.18 Billion DKK	39.16%
2010 Q1	773 Million DKK	6.62%
2010 FY	812 Million DKK	12.0%
2010 Q4	812 Million DKK	10.48%
2010 Q3	735 Million DKK	6.68%
2010 Q2	689 Million DKK	-10.87%
2009 Q4	725 Million DKK	0.0%
2009 FY	725 Million DKK	7.25%
2008 FY	676 Million DKK	-4.65%
2007 FY	709 Million DKK	2.01%
2006 FY	695 Million DKK	-1.7%
2005 FY	707 Million DKK	0.0%

Peer Total Liabilities Comparison of ALK-Abelló A/S

Name	Total Liabilities	Total Liabilities Difference
Bavarian Nordic A/S	4.01 Billion DKK	43.214%
Genmab A/S	3.67 Billion DKK	38.054%
Gubra A/S	145.62 Million DKK	-1465.022%
Novo Nordisk A/S	207.92 Billion DKK	98.904%
Orphazyme A/S	5.07 Million DKK	-44850.69%
Pharma Equity Group A/S	42.4 Million DKK	-5274.493%
Zealand Pharma A/S	1.6 Billion DKK	-41.902%

Global Stocks Search

ALK-Abelló A/S (ALK-B.CO)

Total Liabilities Summary of ALK-Abelló A/S

Annual Total Liabilities Chart of ALK-Abelló A/S (2023 - 2005)

Historical Annual Total Liabilities of ALK-Abelló A/S (2023 - 2005)

Peer Total Liabilities Comparison of ALK-Abelló A/S